US Patent Issued to Regeneron Pharmaceuticals, Yale University, Institute for Research in Biomedicine (IRB) on Aug. 4 for "Genetically modified non-human animals expressing human EPO" (American, Swiss Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,696,884, issued on Aug. 4, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.), Yale University (New Haven, Conn.) and Institute for Research in Biomedicine (IRB) (Bellinzona, Switzerland).

"Genetically modified non-human animals expressing human EPO" was invented by Andrew J. Murphy (Croton-on-Hudson, N.Y.), Sean Stevens (San Francisco), Richard Flavell (Guilford, Conn.), Markus Gabriel Manz (Zurich, Switzerland) and Liang Shan (New Haven, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Genetically modified non-human animals expressing human EPO from the animal genome are provided. Also provided are methods for making non-human animals...